Rockville, Oct. 31, 2022 (GLOBE NEWSWIRE) — Global chest drainage device sales are expected to grow at a CAGR of 4.6% and surpass a $1 billion valuation by 2032, according to Fact.MR, a market research firm. Due to the sudden increase in technological developments in medical devices, the market is expected to grow steadily over the forecast period.
The main purpose of chest drains is to remove air, fluid and particles from the pleural cavity or mediastinum of the chest. The main reason refueling Demand for chest drainage devices is the rising global prevalence of cardiovascular disease, hypertension, diabetes and obesity. Often made of transparent plastics such as soft silicone or PVC, they are used in a range of medical fields such as thoracic surgery, infectious diseases, pulmonology, emergency medicine, general critical care, cardiology, cancer and pain management.
Download sample copy of this report –
https://www.factmr.com/connectus/sample?flag=S&rep_id=7804
Also, increasing demand for early detection and treatment of diseases is expected to accelerate revenue growth in the market. In addition, favorable government reimbursement policies and the rising incidence of spontaneous pneumothorax are expected to boost demand for chest drainage devices.
The growing popularity of minimally invasive procedures and the associated lower healthcare expenses compared to standard surgical procedures are also expected to support device demand growth. Demand for chest wall drainage devices will increase as people become more aware of the impact of MPE and the importance of early diagnosis. The prevalence of heart disease has been increasing worldwide, accounting for 26 million cases in recent years, with millions more unidentified cases. This is due to the increasing aging of the population, the increase in…
